β2 adrenergic receptor antag 
Welcome,         Profile    Billing    Logout  
 1 Company   1 Product   0 Diseases   2 Trials   6 News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gencaro (bucindolol) / ARCA Biopharma
BB-META-HF, NCT00832442: Collaborative Systematic Overview of Randomised Controlled Trials of Beta-Blockers in the Treatment of Heart Failure

Checkmark Redefining β-blocker response in heart failure patients with sinus rhythm and atrial fibrillation: a machine learning cluster analysis.
Checkmark Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis.
Enrolling by invitation
N/A
18240
Europe
Beta blocker, Metoprolol, Bucindolol, Carvedilol, Bisoprolol, Nebivolol, Placebo
Royal Brompton & Harefield NHS Foundation Trust, University of Oxford
Heart Failure
12/12
12/12
propranolol/etodolac (VT-11CR) / Vicus
NCT01265576: Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC)

Checkmark ASCO-GI 2015
Active, not recruiting
2
20
US
Sorafenib, VT-122 (propranolol plus etodolac), Placebo
Vicus Therapeutics
HCC
02/14
04/16
TR4 / Trio Medicines
No trials found
Synbitide HFA MDI (budesonide/procaterol) / Intech Biopharm
No trials found

Download Options